BACTI_B: Q1 2025 saw sustained profitability, revenue growth, and robust Wound Management performance

About this update from Bactiguard Holding Ab

Bactiguard delivered its fourth straight quarter of positive EBITDA, with Q1 2025 revenues up 7% year-over-year and strong growth in Wound Management. Strategic partnerships and updated long-term targets support continued profitable expansion.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Bactiguard Holding Ab